Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,790.08
    +1,460.04 (+2.96%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Company News for Apr 24, 2018

DG vs. TJX: Which Stock Is the Better Value Option?
  • Alaska Air Group, Inc.’s ALK  shares rose 5.7% after reporting first-quarter 2018 earnings of $0.14 per share, surpassing the Zacks Consensus Estimate of $0.11 per share

  • Shares of Associated Banc-Corp ASB increased 0.2% after reporting first-quarter 2018 adjusted earnings of $0.50 per share, surpassing the Zacks Consensus Estimate of $0.41 per share

  • Henry Schein, Inc.’s HSIC shares rose 6.8% on news that the company will spin off its animal health business in order to merge it with Vets First Choice

  • Shares of Humana Inc HUM increased 0.1% after the health insurer announced that it will enter into a partnership with a privately-equity consortium in order to buy Curo Health Services, a privately held hospice facility provider, for $1.4 billion.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alaska Air Group, Inc. (ALK) : Free Stock Analysis Report
 
Associated Banc-Corp (ASB) : Free Stock Analysis Report
 
Humana Inc. (HUM) : Free Stock Analysis Report
 
Henry Schein, Inc. (HSIC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research